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1. Introduction 
The glomerulus is composed of glomerular resident cells, which include podocytes, mesangial 
cells, and glomerular endothelial cells, and is response for glomerular filtration. A range of 
pathogenic conditions can cause structural and functional damage to these glomerular cells, 
including hypertension, diabetes, and inflammation; these induce glomerulonephritis, which 
in turn leads to end-stage renal failure. Extensive investigations have uncovered the molecular 
mechanisms by which glomerulonephritis progresses, including the contribution of cellular 
stress signals induced by oxidative stress, hypoxia, or inflammation.    
The endoplasmic reticulum (ER) is an organelle that maintains protein homeostasis, which 
includes regulation of the concentration, conformation, folding, and trafficking of client 
proteins. ER dysfunction causes an imbalance between protein-folding capacity and protein-
folding load, a condition referred to as ER stress. This stress triggers the accumulation of 
unfolded proteins in the ER and subsequent activation of an intracellular stress signal, the 
unfolded protein response (UPR). ER stress and the UPR can result from various 
disturbances, such as hypoxia, glucose deprivation, and oxidative stress. The UPR, which 
initially serves as an adaptive response to maintain the homeostasis of the ER, induces ER 
resident chaperones, which act to enhance protein-folding capacity, the activation of 
pathways that degrade unfolded proteins accumulated in the ER (ERAD), and the 
attenuation of translation. The physiological level of the UPR transformes to a pathogenic 
response when ER stress is overwhelming or prolonged. At its pathogenic level, the UPR 
produces an apoptotic response, namely the activation of UPR-related proapoptotic 
molecules and inhibition of anti-apoptotic molecules. Accumulating evidence demonstrates 
that ER stress contributes not only to protein conformational diseases, but also to the 
progression of various diseases, including cardiac disease, diabetes, cancer, and kidney 
disease. Given the linkage of ER stress with oxidative stress or hypoxia, both of which are 
pathogenic, it is hardly surprising that the potential pathophysiological significance of ER 
stress is evoked across a wide range of diseases.  
Recent evidence demonstrates that ER stress is a significant contributor to 
glomerulonephritis. Podocytes play an important role in the glomerular filtration barrier 
that is maintained by filtration slits (slit diaphragm), and express various proteins associated 
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with the slit diaphragm. Congenital nephrotic syndrome is caused by genetic mutation of 
slit diaphragm-associated molecules, such as nephrin and -actinin-4. These mutated 
proteins are malfolded and accumulated in the ER of podocytes, and thereby induce the 
UPR, namely ER chaperone expression and proapoptotic gene induction. Mesangial cells are 
responsible for the structural and functional maintenance of glomerular tufts and mesangial 
cell damage in glomerulonephritis is associated with induction of the UPR, which involves 
ER chaperone expression and the attenuation of protein translation. The induction level of 
the UPR increases in parallel with disease progression. These data suggest that the UPR 
maintains ER homeostasis in glomerular cells and ensures cell survival under pathogenic 
conditions. ER stress pathophysiologically contributes to tubulointerstitial damage not only 
in glomeruli, but also tubules. Tubular damage, such as tubular cell death caused by 
proteinuria, ischemia-reperfusion, or nephrotoxin, predominantly enhances the UPR, 
especially UPR-induced apoptosis and autophagy.   
These findings emphasize not only the importance of ER stress as a new progression factor 
but also the interesting future possibility of renoprotective strategies which target ER stress. 
In experimental glomerular and tubular injury model animals, overexpression of GRP78 
(glucose-regulated protein 78), a master regulator of UPR, or administration of the chemical 
compounds that regulate UPR activation shows renoprotective effects. Preconditioning of 
ER stress with non-nephrotoxic dose of ER stress inducers protects against the podocyte and 
mesangial cell damage they induced. Interestingly, some oxidative stress inhibitors and 
advanced glycation inhibitors also act as UPR inhibitors, suggesting a link between 
oxidative stress, hypoxia, and ER stress. Therapeutic approaches which target ER stress may 
act by breaking the vicious cycle of this stress signal crosstalk in kidney disease.  
Here, I summarize the role of ER stress as the master regulator of the stress response in 
glomerular disease and the therapeutic possibility of targeting UPR molecules. 
2. ER stress and the unfolded protein response (UPR) 
The ER plays an important role in the quality control of proteins by the regulating their 
synthesis, folding and trafficking. ER homeostasis depends on a balance in capacity between 
protein synthesis and folding. Various disturbances; decrease folding capacity, including 
folding mutations, hypoxia, or starvation, and thereby induce the accumulation of 
malfolded protein in the ER, which in turn leads to ER stress. This enforces the cellular 
stress signal, called the unfolded protein response (UPR) (Ron & Walter, 2007) (Figure 1). 
The UPR pathway is regulated by three ER resident transducers (ER stress sensors), 
namely inositol-requiring protein-1 (IRE1), protein kinase RNA (PKR)-like ER kinase 
(PERK), and activating transcription factor 6 (ATF6). Under normal conditions, they are 
inactivated by binding with an ER chaperone, glucose-regulated protein 78 (GRP78 or 
BiP). When unfolded proteins accumulate in the ER lumen, however, they are dissociated 
from GRP78, activated by dimerization, phosphorylation, or translocation to the Golgi, 
and then induce signals to attenuate translation or upregulate adaptive UPR target gene 
expression. The three ER resident transducers induce the ER chaperones to enhance 
folding capacity and activate the pathway for ER-associated protein degradation (ERAD) 
to reduce the accumulation of malfolded proteins. The UPR pathway maintains ER 
homeostasis to ensure cell survival.  
When severe ER stress results in excessive or prolonged UPR activation, cells are unable to 
resolve the protein-folding defect or restore ER homeostasis via the adaptive UPR pathway. 
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In these circumstances, the proapoptotic UPR mediated by CHOP (CCAAT/enhancer-
binding protein homologous protein) or caspase 12 is induced to ensure cell death  
(Tabas & Ron, 2011). The UPR pathway is thus a double-edged sword for cells under ER 
stress, and the final outcome represents the sum of the effects of the various possible UPR 
branches. 
 
Under normal conditions 
 
Under ER stress conditions 
 
Adaptive UPR                              Proapoptotic UPR 
   
Fig. 1. Unfolded protein response (UPR) 
Under normal conditions (upper panel), the ER stress sensors IRE1, PERK, and ATF6 are 
inactivated by binding with ER chaperone GRP78. When an imbalance between protein 
synthesis and folding capacity under ER stress causes the accumulation of unfolded proteins 
in the ER, however, these sensors are dissociated from GRP78 and activated by dimerization 
and phosphorylation (IRE1 and PERK) or translocation and cleavage (ATF6), thereby 
inducing the adaptive UPR for cell survival (lower left panel). The adaptive UPR consists of 
1) translation attenuation to ensure a balance of protein synthesis and folding, 2) induction 
of ER chaperone expression to enhance folding capacity, and 3) activation of the ER-
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associated protein degradation (ERAD) system to reduce unfolded protein accumulation. In 
stark contrast, prolonged or severe UPR activation leads to induction of the proapoptotic 
UPR, which is mediated by CHOP and caspase 12 for cell death (lower right panel). The 
balance of UPR states contributes to the consequence of ER stress. IRE1, inositol-requiring 
protein-1; PERK, protein kinase RNA (PKR)-like ER kinase; ATF6, activating transcription 
factor 6; GRP78, glucose-regulated protein 78; CHOP, CCAAT/enhancer-binding protein 
homologous protein. (modified from Reiko Inagi, Curr Opin Pharmacol, 2009 with 
permission)   
2.1 Adaptive UPR: IRE-XBP, PERK-eIF2, and ATF6 pathways 
The IRE1 pathway is initiated by the RNAase activity of IRE1, which induces mRNA 
splicing in X-box-binding protein 1 (XBP1), thereby creating a potent transcriptional 
activator (XBP1s) of genes which encode ERAD components and ER chaperones such as 
GRP78, GRP94, and calreticulin. The IRE1-XBP1 pathway serves mainly as an ER 
homeostatic response to ER stress by degrading or refolding misfolded proteins 
accumulated in the ER lumen. Recent publication of the crystal structure and 
autophosphorylation mechanism of IRE1 protein has provided new insights into the 
regulation mechanism of IRE1-XBP1 axis and subsequently the entire UPR (Lee et at, 2008; 
Ali et al, 2011). 
The PERK pathway alleviates the ER burden by reducing the frequency of initiation of 
mRNA translation, thereby decreasing the influx of new proteins into the ER. PERK is a 
Ser/Thr protein kinase whose active homodimer phosphorylates and inactivates eukaryotic 
initiation factor 2α (eIF2α), thereby shutting off protein translation globally and reducing 
protein load on the ER. In addition to this function, the PERK-eIF2 pathway activates in 
parallel activating transcription factor 4 (ATF4), and thereby selectively induces UPR-
inducible gene expression, including ER chaperones, as well as antioxidant enzymes, such 
as glutathione S-transferase and hemoxygenase 1 (HO-1), to protect cells from both 
oxidative as well as ER stresses (Bardag-Gorce et al, 2010). Although PERK and IRE1 share 
functionally similar ER-luminal sensing domains and are both simultaneously activated in 
cellular paradigms of ER stress in vitro, they are selectively engaged in vivo by the 
physiological stress of unfolded proteins. 
The ATF6 pathway is activated by its transloation to the Golgi where it is cleaved by S1P 
and S2P (site-1 and site-2 proteases). The cytosolic fragment of cleaved ATP6 (p50) further 
translocates to the nucleus, where it subsequently activates the transcription of its target 
genes, which encode ER chaperones and ERAD components. 
2.2 Proapoptotic UPR: CHOP and IRE1-TRAF2 pathways 
ER stress-induced apoptosis is mainly mediated by CHOP, also referred to as GADD153 
(growth arrest and DNA damage 153). CHOP, a transcription factor which induces several 
proapoptotic factors, occurs downstream of the PERK (PERK-ATF4 pathway) and ATF6 
pathways in the proapoptotic UPR axis. The CHOP pathway also down-regulates anti-
apoptotic Bcl-2, leading to enhanced oxidant injury and apoptosis. These findings are 
consistent with the previous observation that overexpression of Bcl-2 specifically in the ER 
protects renal tubular cells against ER stress-induced apoptosis (Bhatt et al, 2008).  
The IRE1-TRAF2 pathway is another proapoptotic UPR branch. The cytoplasmic domain of 
activated IRE1 interacts with the adaptor factor TRAF2 (tumor necrosis factor receptor-
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associated factor 2), leading to activation of both the caspase 12-dependent and JNK-
mediated apoptotic pathways. Several components of the caspase cascade are reported to be 
involved in ER stress-induced apoptosis. In particular, caspase 12, which is associated with 
the ER membrane, is a proximal regulator of ER stress-induced caspase activation followed 
by apoptosis. Caspase 12 is expressed in rodents but not primates, and caspase 4 is instead 
thought to contribute to ER stress-induced apoptosis in human cells.  
ER stress-induced dysfunction of ER Ca+ homeostasis also contributes to apoptosis through 
multiple pathways. Ca+ leaked from the ER lumen enters the mitochondria, depolarizes the 
inner mitochondrial membrane, and generates mitochondrial ROS. This enhanced ROS 
production is associated with a vicious cycle of oxidative stress in both the ER and 
mitochondria, where it activates several apoptotic pathways, including the caspase 9-
mediated or BAX/BAK-mediated pathways. This dispensation with dysfunctional cells 
represents a last resort on the part of multicellular organisms.  
3. Pathophysiology of ER stress in kidney disease 
It was recently established that ER stress is induced in various kidney diseases (Inagi, 2010). 
This is not entirely unexpected given that ER function is easily influenced by various 
cellular stresses. Further, ER stress contributes to disease progression in cardiac, vascular, 
and metabolic diseases, all of which are linked to the development of kidney disease. ER 
stress and consequent imbalance of UPR is one of the potent pathogenic mechanisms of 
kidney disease.    
The initial filtrating component of functional nephrons are the glomeruli, which are 
capillary tufts that receive their blood supply from afferent arterioles of the renal circulation.  
The specialized capillary bed in each glomerulus consists of a network of interconnected 
loops surrounded by Bowman's capsule. Podocytes, which play an important role in the 
filtration barrier, have foot processes that extend over the glomerular basement membrane. 
These foot processes are bridged by slit diaphragms (filtration barrier) which connect 
adjacent foot process and thereby act to prevent larger molecules filtering into Bowman's 
capsule. Mesangial cells, some of which have phagocytic properties, are located between the 
capillary loops, and form the central stalk of the glomerulus. These form part of the 
functional nephron unit and interact closely with endothelial cells and indirectly with 
podocytes. Recent evidence increasingly emphasizes the link between ER stress and both 
glomerular cell damage and tubulointerstitial injury. 
3.1 Podocytes and ER stress 
Mutation of components of the slit diaphragms, including nephrin and alpha-actinin-4, 
leads to congenital nephrotic syndromes. These mutations are mostly associated with 
conformational abnormalities. Thus, they induce defects in the related protein trafficking 
and retention of mutant proteins in the ER, and thereby lead to ER stress in podocytes. 
Indeed, Cybulsky and collegues have demonstrated that mice overexpressing human 
mutated alpha-actini-4 develop the pathological and functional features of congenital 
nephrotic syndrome, including podocyte injury and proteinuria. They also show 
associated ER stress, namely an increase in ER chaperones and adaptive and proapoptotic 
UPR molecules (Cybulsky et al, 2009), suggesting that ER stress in podocytes contributes 
to congenital nephrotic syndrome. We have also demonstrated that ER stress is induced 
by malfolded protein accumulation in podocytes, and that this leads to proteinuria. We 
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previously established a transgenic rat in which the protein encoded by the transgene 
(megsin, a kidney specific serine protease inhibitor) is consistently malfolded and 
polymerized under overexpression conditions and accumulated in the ER lumen of 
podocytes (Inagi et al, 2005a). Pathological changes in these podocytes, such as ER 
dilation, were associated with severe proteinuria. Importantly, these transgenic rats 
showed an increase in ER chaperone expressions in damaged podocytes, including GRP78 
or oxygen-regulated protein 150 (ORP150) (Inagi et al, 2005b). Collectively, these data 
suggest that the decline in protein-folding capacity in podocytes triggers cellular 
dysfunction which in turn results in derangement of the structure of slit diaphragms and 
thereby causes proteinuria.    
We have also established an advanced diabetic nephropathy model mouse, which develops 
severe albuminuria and renal damage with all of the characteristics of human advanced 
diabetic nephropathy, such as acellular nodule-like lesions (Inagi et al, 2006). 
Immunohistochemistry for the detection of GRP78 revealed that these changes were 
associated with ER stress mainly in podocytes. (Inagi R, unpublished data) 
ER stress induction in podocytes was further confirmed by studies utilizing the XBP1-venus 
fusion Tg mouse, which is an ER stress monitoring mouse (Iwawaki et al, 2004). These mice 
produce XBP1-GFP fusion protein only when XBP1 is activated by alternative splicing under 
ER stress conditions, and not under normal conditions. On treatment with anti-GBM 
antibody, a model of rapidly progressive glomerulonephritis, untreated mice showed the 
basal level of GFP expression in podocytes. In contrast, this expression was significantly 
increased in the diseased mice in association with proteinuria. This finding suggests that the 
XBP-1 axis is activated in damaged podocytes.  
Taken together, our and previous findings demonstrating UPR activation in other podocyte-
injury disease models (e.g., membranous nephropathy and minimal change nephrotic 
syndrome) highlight the link between ER stress and podocyte homeostasis, and that the ER 
stress state in podocytes might be changed by these various factors.   
3.2 Mesangial cells and ER stress 
Mesangioproliferative glomerulonephritis, which is caused by mesangial cell damage, is one 
of the major glomerulonephritises. We previously demonstrated that ER chaperone 
expression was significantly increased in the damaged mesangial area in anti-Thy1 nephritis 
rats, a representative mesangioproliferative glomerulonephritis model (Inagi et al, 2008). For 
example, immunohistochemistry for the detection of GRP78 and ORP150 followed by 
quantitative morphometry confirmed that the UPR for the induction of ER chaperone 
expression was markedly enhanced as the disease progressed. Similar results were observed 
by Western blot analysis followed by densitometry utilizing isolated glomeruli in 
experimental rats. Further, another adaptive UPR axis for translation attenuation was also 
significantly increased, as estimated by the phosphorylation of PERK and eIF2. These data 
emphasize the association between mesangial cell damage and ER stress, and that 
significant activation of the adaptive UPR axis contributes to the progression of 
glomerulonephritis. Given that oxidative stress is also induced in anti-Thy1 nephritis rats, 
mesangial cell damage may be orchestrated by the link between ER stress and oxidative 
stress as pathogenic mediators.  
This evidence from a rat disease model might be consistent with evidence that ER stress 
estimated by GRP78 and CHOP expression is higher in patients with proliferative 
glomerulonephritis than in those with other glomerular diseases (Markan et al, 2009). 
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Table 1. Triggers for ER stress in podocytes 
Various pathogenic factors trigger ER stress in podocytes. Heymann nephritis and 
puromycin nephrosis are representative experimental animal disease models which mimic 
human membranous nephropathy and minimal change nephrotic syndrome, respectively. 
3.3 Tubular cells and ER stress 
Several disturbances have been shown to induce ER stress in tubules as cellular damage 
progresses. (Table 2) Among them, we showed that the proapoptotic UPR axis, which is 
predominantly mediated by caspase 12, is induced by proteinuria and contributes to tubular 
cell death in a minimal change nephrotic syndrome model rats (puromycin nephropathy) 
(Ohse et al, 2006). In chronic kidney disease, we further showed that uremic toxin might act 
as an ER stress inducer. In particular, in chronic kidney disease model rats (5/6-
nephrectomized rats), CHOP-positive tubular cells were significantly increased in parallel 
with the accumulation of a representative uremic toxin, indoxyl sulfate, in the serum 
(Kawakami et al, 2010). These changes were ameliorated by the administration of a uremic 
toxin absorbent, AST-120, clearly suggesting the causal effect of indoxyl sulfate in ER stress 
induction in tubular cells.  
Not only in experimental animals but also in humans, mRNA levels of ER chaperons 
(GRP78 and ORP150) and URP transcription factors (XBP1 and CHOP) in tubules is 
increased in patients with both advanced diabetic nephropathy and minimal change 
nephrotic syndrome as compared with healthy individuals (Lindenmeyer et al, 2008).    
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Table 2. Triggers for ER stress in tubular cells. 
3.4 Other kidney cells and ER stress 
While ER stress is induced in retinal endothelial cells and pericytes in diabetic retinopathy, the 
role of ER stress in glomerular endothelial or tubulointerstitial cells is still unclear. 
Tubulointerstitial cells are heterogeneous, and a certain subpopulation of these cells includes 
pericyte-like cells producing erythropoietin (EPO). The role of ER stress in tubulointerstitial 
cells is an interesting issue, particularly its contribution to the regulation of EPO expression.  
Recently, it was demonstrated that renal anemia is not due to loss of EPO-producing cells 
but rather derangement of the oxygen-sensing mechanism which regulates EPO expression 
(Bernhardt et al, 2010). We investigated the effect of ER stress on EPO production in an EPO-
producing hepatic cell line, HepG2. Hypoxia-induced EPO mRNA expression was 
significantly blunted by ER stress in HepG2 when the cells were treated with the ER stress 
inducer tunicamycin under low oxygen tension (Chiang CK, et al., unpublished data). Our 
observations suggest that renal pathogens, which can trigger ER stress, derange renal EPO 
production capacity and may thereby enhance the development of renal anemia. Further 
studies of the suppressive mechanism of this finding are under way. 
4. ER stress and other stress signals  
It is known that ER stress is initiated by hypoxia or oxidative stress and vice versa. Hypoxia 
and oxidative stress induce the cellular stress signals, namely the hypoxia-inducible factor 
(HIF) and NF-E2-related factor 2 (Nrf2) pathways, respectively. Imbalance of these stress 
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signals contributes to the pathological features of various kidney diseases (e.g., diabetic 
nephropathy, ischemia-reperfusion injury, glomerulonephritis) (Nangaku, 2006), which are 
also associated with ER stress. This suggests that the UPR, HIF, and Nrf2 pathways are 
linked, and that stress signal crosstalk might orchestrate the disease progression. 
4.1 UPR and HIF pathway  
Hypoxia, leading to the loss of energy, initiates a defect in protein-folding capacity, and 
thereby induces UPR activation. In tumor cells, for example, the hypoxic microenvironment 
brought on by poor vascularization brings about ER stress due to the loss of energy for 
protein folding. It has now been established that not only the HIF pathway but also the UPR 
is crucial to the survival of tumor cells against their hypoxic microenvironment: increased 
expression of ER chaperones, which enhances protein-folding capacity, is observed in a 
wide range of human cancers, and expression level correlates with tumor progression, 
metastasis, and drug resistance (Lee, 2007).  
Further, it has also been demonstrated that the HIF pathway upragulates the expression of the 
UPR molecules, indicating the presence of molecular crosstalk between the HIF and URP 
pathways. Cultured endothelial cells under hypoxia showed an increased in GRP78, GRP94 
and caspase 12 expressions. A chemical stabilizer of HIF, CoCl2, also increased the expression 
of both GRP78 and GRP94, revealing that HIF activation alters UPR state (Ostergaard et al, 
2009). Conversely, ER stress by tunicamycin and brefeldin A triggered HIF-1 mRNA 
expression in the human hepatocyte cell line HepG2 under hypoxia (Werno et al, 2008). These 
findings suggest the presence of positive feedback between the HIF pathway and the UPR 
under hypoxic conditions and the possibility of indirect regulation of the HIF pathway by the 
UPR. In addition, one study demonstrated that certain UPR molecule expression is 
translationally regulated by an HIF regulator: ATF4, a UPR transcription factor, alters its 
protein stability through interaction of the zipper II domain of ATF4 with the oxygen sensor 
prolyl-4-hydroxylase domain 3 (PHD3) (Koditz et al, 2007). PHDs are well-known regulators 
of HIF, and treatment with the PHD inhibitor increased ATF4 protein levels. These data 
demonstrate that PHD-dependent oxygen-sensing recruits both the HIF and ATF4 systems in 
parallel. To further emphasize the biological significance of interaction between the HIF and 
ER stress pathways, studies utilizing C. elegans showed that HIF-1 deficiency extended lifespan 
in a UPR transducer IRE-1-dependent manner (Chen et al, 2009) 
4.2 UPR and oxidative stress 
Oxidative stress as well as hypoxia initiates ER stress (Malhorta & Kaufman, 2007). Nitric 
oxide (NO), produced in excessive levels following ischemia, contributes to ER stress. 
Ischemia-reperfusion-induced activation of the PERK-eIF2 axis for translation attenuation 
is blocked in endothelial or neuronal NO synthase (NOS) knockout mice with bilateral 
carotid artery occlusion (DeGracia & Montie, 2004). Consistent with this, the NO-releasing 
reagent SNAP activates the PERK pathway, indicating that NO plays a role in the ischemia-
reperfusion-induced UPR. Pretreatment with neuroprotective levels of an NOS inhibitor 
recovered the proapoptotic UPR state induced by a ischemia-induced defect in ER Ca2+ 
homeostasis, which occurs due to Ca2+ leakage into the cytosol and subsequent uptake into 
mitochondria, resulting in mitochondrial ROS generation. The aberrant NO production seen 
in hypoxia, which alters calcium homeostasis in both the ER and mitochondria, may initiate 
a vicious cycle of ER stress, oxidative stress, and apoptosis. 
Under oxidative stress, reactive oxygen species (ROS) interfere with not only cellular redox-
dependent reactions but also protein-folding capacity, including protein disulfide bonding, 
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ultimately resulting in protein misfolding in the ER. Studies utilizing the overexpression of 
anti-oxidant enzymes have emphasized the linkage of oxidative stress to the ER stress 
response. The ischemia-induced ER stress response was markedly less pronounced in animals 
overexpressing copper/zinc superoxide dismutase (Cu/Zn-SOD), suggesting that superoxide 
radicals play a role in this pathological process (Hayashi et al, 2003). Further, cadmium caused 
the generation of ROS with subsequent induction of ER stress in a cultured renal proximal 
tubular cell line, which in turn led to apoptosis; this cadmium-induced ER stress and apoptosis 
were significantly attenuated by manganese SOD overexpression (Yokouchi et al, 2008). 
Paradoxically, ER stress also increases intracellular ROS production: increased protein 
disulfide bonding enhances ROS production in the ER lumen, and alteration of ER Ca+ 
homeostasis increases cytosolic Ca+, thereby stimulating mitochondrial ROS production. Of 
particular note, recent studies have demonstrated that the accumulation of intracellular ROS is 
attenuated by the adaptive UPR through PERK activation, which simultaneously activates an 
anti-oxidative stress signal, the Nrf2 pathway, and maintains redox homeostasis, thereby 
ensuring cell survival. The antioxidant effects of the PERK axis of the UPR are supported by 
the finding that PERK-deficient cells exposed to tunicamycin, an ER stress inducer, showed a 
toxic accumulation of intracellular ROS compared to wild-type cells (Cullinan & Diehl, 2006). 
Translation attenuation through the PERK-eIF2 pathway effectively prevents the misfolded 
protein-inducible oxidative stress and maintains the cell (Back et al, 2009).  
4.3 UPR and advanced glycation 
Under oxidative stress conditions with hyperglycemia, proteins and DNA are non-
enzymatically modified by oxidative glycation, which occurs mainly due to increased ROS 
generation, and converted to advanced glycation endproducts (AGEs). Advanced glycation is 
one of the major pathophysiological posttranslational modifications and induces the 
derangement of protein functions or apoptosis. Functional abnormalities of glycated proteins 
perturb cellular homeostasis and increase mitochondrial ROS generation, accelerating the 
vicious cycle of oxidative stress and thereby enhancing subsequent glycation modification. 
From the viewpoint that ER stress is predominantly induced by hypoxic or oxidative stress, it 
is reasonable to speculate the presence of a link between advanced glycation and ER stress on 
the disease development and progression caused by these disturbances.  
It has been reported that AGEs induce ER stress directly. Among findings, it is reported that 
glycated serum albumin (AGE-bovine serum albumin) induces ER stress, as estimated by 
GRP78 expression, and apoptosis in a dose- and time-dependent manner in mouse 
podocytes via an increase in intracellular Ca2+ concentration. ER stress inhibitor taurine-
conjugated ursodeoxycholic acid (TUDCA), which acts as a chaperone that promotes the 
folding and trafficking of unfolded or malfolded proteins, prevents AGE-induced apoptosis, 
suggesting that this apoptosis is mediated by the apoptotic UPR pathway (Chen et al., 2008). 
Like glycated albumin, extracellular matrix is frequently modified by advanced glycation in 
the skin of diabetic patients. The advanced-glycated type I collagen also causes proapoptotic 
UPR-mediated apoptosis via CHOP activation in dermal fibroblasts, suggesting a 
pathophysiological role for the link between advanced glycation and ER stress in diabetic 
wounds (Loughlin & Artlett, 2010).  
5. Therapeutic approach targeting ER stress in kidney disease 
Accumulating evidence, including ours, has recently indicated the therapeutic benefits of 
targeting ER stress in various diseases, including cardiac, vascular, and metabolic diseases 
as well as kidney disease. Therapeutic modalities which targeting ER stress are summarized 
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in Table 3. While artificial modulation of ER stress may provide protection to various kinds 
of cells (Kim et al, 2008), this chapter focuses on the beneficial effects on kidney disease. 
 
 
Table 3. Therapeutic modalities targeting ER stress. 
Abberant UPR state, which contributes to the progression of various diseases, is suppressed 
by ER chaperone overexpression, the chemical chaperones themselves, or chemical 
compounds which selectively activate the adaptive UPR axis or suppress the apoptotic UPR 
axis. ER stress preconditioning upregulates the basal UPR state and protects cells from 
variuos pathogenic stresses. 
5.1 ER chaperones and chemical chaperones 
ER chaperone overexpression (e.g., GRP78 and ORP150) and chemical or pharmaceutical 
chaperones (e.g., 4-phenyl butyric acid (PBA), TUDCA, and dimethyl sulfoxide) stabilize 
protein conformation, enhance ER protein-folding capacity to normalize the imbalance of 
protein synthesis and folding, and thereby maintain ER homeostasis. In particular, protein 
folding augmentation therapies utilizing these UPR modulators or chemical chaperones 
may improve conditions associated with protein malfolding, such as congenital nephrotic 
syndromes, which are caused by a defect in the retention and accumulation of mutant 
proteins in the ER of podocytes. 
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As the evidences for the effectiveness of ER chaperone enhancement in the kidney, ORP150 
transgenic mice showed resistance to renal ischemia-reperfusion injury (Bando et at, 2004). 
4-Phenylbutyric acid (4-PBA), a chemical chaperone, rescues mutated nephrin, which is 
associated with misfolding and mislocalization, from the ER to the cell surface, suggesting 
the beneficial effect of protein folding augmentation therapy in congenital nephrotic 
syndrome (Liu et al, 2004). 4-PBA also exerts a marked renoprotective effect possibly by 
modulating ER stress and the related inflammatory cascade in diabetic nephropathy (Qi et 
al, 2011). Endogenous bile acids and derivatives such as ursodeoxycholic acid and its 
taurine-conjugated derivative (TUDCA) can also modulate ER function, restore glucose 
homeostasis in type 2 diabetic mice, and thereby ameliorate the development of diabetic 
complications, including diabetic nephropathy in these animals (Xie et al, 2002; Ozcan et al, 
2006; Ozcan et al, 2009). In studies of TUDCA therapy for obese men and women, TUDCA 
has consistently shown promise as an effective pharmacological approach to the treatment 
of insulin resistance and obesity-related disease including chronic kidney disease (Kars et al, 
2010). Unlike 4-PBA, however, TUDCA has not been shown to act as a chaperone that 
promotes the folding and trafficking of malfolded proteins; instead, it is likely to increase 
folding capacity, possibly by enhancing the ERAD pathway (ER-associated malfolded 
protein degradation system). Murine podocytes suffered from ER stress-induced apoptosis 
on exposure to advanced glycation end product (AGE)-modified bovine serum albumin, but 
TUDCA prevented this apoptosis by suppressing the apoptotic UPR activation (Chen et al, 
2008).  
Aberrant UPR state, which contributes to the progression of various diseases, is suppressed 
by ER chaperone overexpression, the chemical chaperones themselves, or chemical 
compounds which selectively activate the adaptive UPR axis or suppress the apoptotic UPR 
axis. ER stress preconditioning upregulates the basal UPR state and protects cells from 
various pathogenic stresses.  
5.2 Chemical UPR modulators 
Chemical compounds which selectively activate the adaptive UPR branches act as enhancers 
of translation attenuation as well as of ER chaperone expression. Other chemical compounds 
which suppress the proapoptotic UPR branches protect cells from ER stress-induced cell 
death. The UPR pathway is a double-edged sword for cells suffering from ER stress; 
normalization of the balance between the adaptive and proapoptotic UPR branches by these 
chemical compounds might thus be effective in promoting ER homeostasis.  
Several chemical compounds have demonstrated renal protective effects against ER stress 
suggesting the therapeutic possibility of targeting the UPR. Trans-4,5-dihydroxy-1,2-
dithiane (DTTox) protected the proximal tubular epithelium against a nephrotoxic chemical 
via stimulation of GRP78 (Asmellash et al, 2005), while BIX (BiP inducer X, 1-(3,4-
dihydroxyphenyl)-2-thiocyanato-ethanone) ameliorated disease manifestations of renal 
ischemia-reperfusion injury in mice by activating the ATF6 axis with subsequent induction 
of GRP78 (Prachasilchai et al, 2009). Salubrinal suppresses the protein phosphatases 
responsible for the dephosphorylation of eIF2α, and significantly reduces tubular injury in a 
rat cyclosporine nephropathy model by increasing the amounts of phosphorylated eIF2α 
(Pallet et al, 2008). Methoxyflavone, a group of flavonoids, is also identified as a strong ER 
stress modulator. Pretreatment of mice with tangeretin, a methoxyflavone, enhanced the 
expression of GRP78 and HO-1 in renal tubular epithelium and prevented tunicamycin-
induced cell death (Takano et al, 2007). 
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5.3 Others  
The previous evidences regarding the crosstalk of oxidative stress, hypoxia, and ER stress 
emphasize that anti-oxidative stress or anti-hypoxia drugs may also hold promising in 
reducing pathogenic ER stress. In fact, effective attenuation of the ER stress response has 
also been observed in compounds which suppress oxidative stress. TM2002, an inhibitor of 
oxidative protein glycation, shows renoprotective effects against glomerular and tubular 
interstitial damage in association with a decrease in ER stress in anti-Thy1 nephritis and 
renal ischemic-reperfusion rats (Izuhara et al, 2008). Further, a chemical HIF stabilizer, 
prolyl hydroxylase inhibitor (Dimethyloxalylglycine) which attenuates ischemic cardiac 
injury by HIF pathway activation, selectively activates the adaptive UPR (GRP78 and ATF4 
inductions), and weakens the proapoptotic UPR, suggesting that HIF stabilizer has the 
renoprotective effects as a UPR modulator (Natarajan et al, 2009). 
One study demonstrated that treatment with mizoribine, an immunosuppressant used 
clinically, reduced ER stress and rescued the mislocalization of nephrin from the ER to the 
cytoplasm in podocytes with glucose starvation. Mizoribine is known to inhibit purine 
nucleotide biosynthesis, and might thereby restore the intracellular energy balance under 
ER stress by salvaging ATP levels. These data suggest that the effect of mizorbine in 
inducing the remission of proteinuria in human nephrotic syndrome might be mediated by 
a reduction in ER stress (Nakajo et al, 2007).  
Further, similar inhibitory effects to those of mizoribine on ER stress were seen with another 
clinically used anti-hypertensive drugs, namely angiotensin converting enzyme (ACE) 
inhibitors and angiotensin II type 1 receptor blockers. The angiotensin II type 1 receptor is 
thought to be an ER stress inducer, albeit that the molecular mechanisms by which 
angiotensin II induces ER stress remain unclear. It is therefore reasonable to consider that 
the increased tubular apoptosis in experimental diabetic rats is attenuated by ACE inhibitors 
in association with a reduction in aberrant apoptotic UPR activation and subsequent 
maintenance of the physiological UPR state in the tubulointerstitium (Sun et al, 2009) 
5.4 ER stress preconditioning 
The effects of ER stress preconditioning highlight the possibility of therapy based on ER 
stress. The concept of preconditioning was originally identified in ischemic diseases. Brief 
ischemic treatment for preconditioning prior to the subsequent insult induces a state of 
resistance to the loss of blood supply by initiating cellular protective responses in the tissue. 
These findings suggest that ER stress preconditioning may initiate the adaptive UPR and 
attenuate the subsequent insult. An increasing number of reports have demonstrated the 
beneficial effects of preconditioning in ER stress-related diseases, such as cardiac and 
neuronal diseases and retinopathy. 
To evaluate the beneficial effect of ER stress preconditioning in kidney disease, we 
investigated whether a non-nephrotoxic dose of the ER stress inducers tunicamycin or 
thapsigargin for preconditioning ameliorate the development of anti-Thy1 nephritis, a 
mesangioproliferative glomerulonephritis model. As we expected, disease progression was 
dramatically improved by preconditioning, in association with a decrease in microaneurysm 
formation, adhesion of Bowman’s capsule to the tuft, and proteinuria (Inagi et al, 2008). 
Importantly, the protective effect of preconditioning against glomerular damage was 
associated with modulation of the adaptive UPR. While the expression of ER chaperones 
(GRP78 and ORP150) was significantly increased as the disease progressed, the 
preconditioning slightly enhanced the basal level of this expression and significantly 
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suppressed the aberrant ER chaperone expression after disease induction. Similarly, 
preconditioning slightly enhanced the basal level of the PERK-eIF2 axis in translation 
attenuation and suppressed its augmentation by disease induction. These findings 
demonstrate that ER preconditioning induces a robust basal (physiological) UPR state and 
maintains a stable UPR level in the kidney. 
Other reports have also emphasized the effectiveness of ER stress preconditioning in the 
kidney. Preconditioning with tunicamycin or doxorubicin mitigates experimental 
membranous nephropathy via ER chaperone enhancement (Cybulsky et al, 2002). Kitamura 
and colleagues extensively investigated the role of ER stress in inflammation, and clearly 
showed that inflammatory cytokine-induced NF-B activation in mesangial cells was 
suppressed by preconditioning via the IRE1-XBP1 axis (Hayakawa et al, 2010). 
 
 
Table 4. ER stress preconditioning in kidney disease 
Preconditioning with an ER stress inducer such as tunicamycin and thapsigargin confers a 
protective effect against kidney disease. BIX is a GRP78 inducer, 1-(3,4-dihydroxyohenyl)-2-
thiocyanate-ethanone which markedly induces GRP78 production and is preferentially 
mediated by the ATF6 pathway. 
6. Conclusion 
The physiological state of the UPR pathway is important to the maintenance of ER 
homeostasis. Under pathogenic conditions, however, ER stress and the subsequent 
overwhelming UPR activation are significantly induced in various kidney cells and 
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contribute to kidney disease progression rather than regulating ER homeostasis. 
Enhancement of the basal level of the UPR, particularly the adaptive UPR axis, might 
support appropriate ER homeostasis and a robust cell state. Cells might accordingly become 
resistant to pathogenic factors, and an aberrant UPR might be suppressed (Fig. 2).  
It is now established that ER stress is involved in cardiac, vascular, and metabolic diseases, 
which in turn affect kidney disease development. UPR is intricately linked to two other 
important stress pathways, HIF and Nrf2, which also contribute to disease progression. 
Keeping intact the balance of these stress signal networks via regulation of the UPR will 
allow us to maintain cellular homeostasis and disease prevention.  
 
 
Fig. 2. ER stress preconditioning in the kidney. 
Under pathogenic conditions, the basal UPR for ER homeostasis transformed to the 
pathogenic state, and thereby leads to the features of ER stress-related kidney diseases. In 
contrast, preconditioning with ER stress enhances the basal UPR level and induces kidney 
cells to develop resistance to pathogens.    
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